PTH and parathyroid hyperplasia: There is a balance to be found when managing rising PTH levels, as parathyroid hyperplasia, persistent elevation of PTH, and the progression of SHPT resulting from delayed therapeutic interventions are accompanied by continuing reductions in sensitivity to vitamin D and calcium homeostasis, subsequently posing a risk of treatment resistance in later stages of the disease [6].